Learning and Development for Innovation and Resilience in The ‎Pharmaceutical Industry

  • Authors

    • Ms. Uma Sundari  U Research Scholar, Department of OD & HR, GITAM School of Business, GITAM Deemed to be University, Visakhapatnam, India
    • Dr. Suresh Sirisetti Assistant Professor, Department of OD & HR, GITAM School of Business, GITAM Deemed to be University, Visakhapatnam, India
    https://doi.org/10.14419/bjsjp624

    Received date: October 6, 2025

    Accepted date: November 25, 2025

    Published date: December 7, 2025

  • Learning and Development; Pharmaceutical Industry; Workforce Competitiveness; Innovation, ‎Compliance; Systematic Literature Review

  • Abstract

    In the pharmaceutical industry, learning and development (L&D) has evolved from a compliance-oriented training function to a strategic enabler of workforce competitiveness, innovation, and ‎organizational resilience in recent years. However, research on L&D in the pharmaceutical industry ‎remains fragmented and requires a systematic synthesis. A systematic literature review (SLR) was ‎conducted following the PRISMA 2020 guidelines. Using predefined search strings in Scopus, peer-reviewed journal articles from 2015 to 2025 in Business and Economics were retrieved, and 1,769 ‎records were screened, resulting in 58 studies being included in the review. Publication trends, leading ‎journals, geographical distribution, and themes of the literature were examined using descriptive and ‎thematic analyses. While there was an increase in publications in the literature, most were published ‎between 2021 and 2023, likely due to the increased focus on upskilling the workforce and digital ‎transformation during the COVID-19 pandemic. The leading journals were the Journal of Business ‎Research, Human Resource Development International, and Management Decision, and research was ‎concentrated in the United States, Europe, India, and China, with little evidence of collaborative ‎networks among them. The dominant themes included digital training, leadership development, ‎regulatory learning, and workforce reskilling, and the conceptual frameworks included the Knowledge-Based View and Human Capital Theory, although few were tailored to the pharmaceutical industry’s ‎regulatory context. The study outcomes emphasized enhancements in employee performance, ‎innovation capacity, compliance, and organizational growth. This review suggests that L&D is a ‎strategic imperative in the pharmaceutical industry and can drive competitiveness. However, gaps exist, ‎particularly in longitudinal studies, AI-driven learning evaluations, and research on emerging ‎economies‎.

  • References

    1. Al‐Haqan, A., Smith, F., & Bates, I. (2020). A global evidence review of systemic factors influencing participation in pharmacy professional develop-ment activities. Research in Social and Administrative Pharmacy, 17(3), 488. https://doi.org/10.1016/j.sapharm.2020.04.019.
    2. Bonanno, P. V., Cassar, V., & Godman, B. (2021). A review of the evidence on attitudes, perceived impacts, and motivational factors for European Member State collaboration for pricing and reimbursement of medicines. Frontiers in Pharmacology, 12, 666405. https://doi.org/10.3389/fphar.2021.666405.
    3. Caratozzolo, P., Smith, C. J., Gómez, S., Moris, M. U., Nørgaard, B., Heiß, H.-U., Schrey‐Niemenmaa, K., & Hadzilacos, R. (2024). A novel taxon-omy for continuing engineering education. Research Portal Denmark, 17. https://local.forskningsportal.dk/local/dki-cgi/ws/cris-link?src=aau&id=aau-b150e6e4-6667-4ccd-9b7d-a400bc5f7368.
    4. Castillo-Apraiz, J., & Matey de Antonio, J. (2018). Does quality pay in the pharmaceutical industry? The mediating role of training of personnel be-tween quality management and performance. Revista de Dirección y Administración de Empresas, 25, 1–17.
    5. Castillo-Apraiz, J., & Matey de Antonio, J. (2020). The mediating role of personnel training between innovation and performance: Evidence from the German pharmaceutical industry. Cuadernos de Gestión, 20(3), 41–52. https://doi.org/10.5295/cdg.180990jc.
    6. Chakraborty, P. (2022). An investigational study on factors of quality culture in pharmaceutical manufacturing sectors. Shanlax International Journal of Management, 9, 146. https://doi.org/10.34293/management.v9iS1.4855.
    7. Chen, X., & Wong, J. (2024). Artificial intelligence and workforce transformation in regulated industries. Journal of Business Research, 167, 112345.
    8. Das, T. K., Maharana, N., Padhi, B. B., Das, C., & Agnihotry, J. (2025). The future revolution in the pharmaceutical industry: Impact of AI, robotics, and automation on diverse job sectors. International Journal of Pharmaceutical Sciences, 3(6), 3340–3348.
    9. Dima, J., Gilbert, M., Dextras-Gauthier, J., & Giraud, L. (2024). The effects of artificial intelligence on human resource activities and the roles of the human resource triad: Opportunities and challenges. Frontiers in Psychology, 15, 1360401. https://doi.org/10.3389/fpsyg.2024.1360401.
    10. Donthu, N., Kumar, S., Mukherjee, D., Pandey, N., & Lim, W. M. (2021). How to conduct a bibliometric analysis: An overview and guidelines. Journal of Business Research, 133, 285–296. https://doi.org/10.1016/j.jbusres.2021.04.045.
    11. Falola, H. O., Ogueyungbo, O., & Ojebola, O. (2020). Influence of workplace management initiatives on talent engagement in the Nigerian pharma-ceutical industry. F1000Research, 9, 699. https://doi.org/10.12688/f1000research.23851.2.
    12. Gupta, R., & Singh, P. (2021). Workforce development in knowledge-intensive industries: Insights from pharmaceuticals. International Journal of Training and Development, 25(3), 245–260. https://doi.org/10.1111/ijtd.12205.
    13. Hökkä, P., Vähäsantanen, K., & Paloniemi, S. (2019). Emotions in learning at work: A literature review. Vocations and Learning, 13(1), 1–26. https://doi.org/10.1007/s12186-019-09226-z.
    14. Hu, Z., Sarfraz, M., Khawaja, K. F., Shaheen, H., & Mariam, S. (2022). The influence of knowledge management capacities on pharmaceutical firms’ competitive advantage: The mediating role of supply chain agility and moderating role of inter-functional integration. Frontiers in Public Health, 10, 953478. https://doi.org/10.3389/fpubh.2022.953478.
    15. Johnson, M. (2025). Strategic learning and compliance in global pharmaceutical companies. Journal of Business Strategy, 46(2), 33–45.
    16. Kamenda, M., & Qutieshat, A. (2021). Uses of the outcomes of research in business management and profitability. Open Journal of Business and Management, 9(6), 2938–2951. https://doi.org/10.4236/ojbm.2021.96164.
    17. Kumar, S., & Bansal, V. (2019). Learning and development as a driver of innovation in emerging markets. Management Decision, 57(8), 2121–2135.
    18. Mahssouni, R., Touijer, M. N., & Makhroute, M. (2022). Employee compensation, training, and financial performance during the COVID-19 pan-demic. Journal of Risk and Financial Management, 15(12), 559. https://doi.org/10.3390/jrfm15120559.
    19. Mehta, A. (2024). Leadership and digital learning adoption in the pharmaceutical workforce. Human Resource Development International, 27(1), 45–62.
    20. Mensah, K. (2025). Regulatory learning and workforce upskilling in global industries. European Management Journal, 43(4), 550–563. https://doi.org/10.1016/j.emj.2025.01.004.
    21. Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., … Moher, D. (2021). The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ, 372, n71. https://doi.org/10.1136/bmj.n71.
    22. Pappa, D. D., Stergioulas, L. K., & Telonis, P. (2009). The role of knowledge management in the pharmaceutical enterprise. International Journal of Technology Management, 47(1–3), 127–144. https://doi.org/10.1504/IJTM.2009.024118.
    23. Patel, P. (2024). Impact of AI on manufacturing and quality assurance in medical device and pharmaceuticals industry. International Journal of Innova-tive Technology and Exploring Engineering, 13(9), 9–15. https://doi.org/10.35940/ijitee.I9949.13090824.
    24. Peng, X., Wang, N., Magagna, W., Land, S. M., & Peck, K. L. (2022). Learning agility of learning and development professionals in the life sciences field during the COVID-19 pandemic: Empirical study. Interactive Journal of Medical Research, 11(1), e33360. https://doi.org/10.2196/33360.
    25. Peters, M., Pérez-Navarro, A., & Fàbregues, S. (2022). A systematic mapping of e-learning research: An interdisciplinary and multi-paradigmatic per-spective from the Universitat Oberta de Catalunya. Electronic Journal of E-Learning, 20(4), 451–470. https://doi.org/10.34190/ejel.20.4.2327.
    26. Rademaker, T., Klingenberg, I., & Süß, S. (2023). Leadership and technostress: A systematic literature review. Management Review Quarterly, 73(1), 123–145. https://doi.org/10.1007/s11301-023-00385-x.
    27. Ramy, A., Ragab, M., & Arisha, A. (2020). Knowledge management in the pharmaceutical industry between academic research and industry regula-tions. Knowledge Management Research & Practice, 20(2), 202–214. https://doi.org/10.1080/14778238.2020.1767517.
    28. Randstad Enterprise. (2025). 2025 talent trends: Life sciences & pharma. Randstad Enterprise. https://www.randstadenterprise.com/insights/white-paper-and-report/life-sciences-talent-trends-ebook.
    29. Sahadev, C. (2024). Agile and design thinking in pharma and healthcare: A systematic review of requirement gathering and user adoption. Research Square, rs.3.rs-5242951/v1. https://doi.org/10.21203/rs.3.rs-5242951/v1.
    30. Shabaninejad, H., Safari, H., Roudbari, M., & Teymourzadeh, E. (2014). Strategic human capital development in pharmaceuticals. Iranian Journal of Public Health, 43(3), 352–360.
    31. Sharma, R. C. (2019). Global perspectives on pharmaceutical leadership. Journal of Pharmaceutical Policy and Practice, 12(1), 45.
    32. Sharma, R. C., & Kohli, D. (2023). Embracing digital transformation for sustainable development: The synergy between learning organizations, hu-man resource management, and service quality. Journal of Chinese Human Resource Management, 14(3), 3–19. https://doi.org/10.47297/wspchrmWSP2040-800501.20231403.
    33. Sormare, G., Dongaonkar, A., Mane, D., Deotale, S., Tijare, R., Awandekar, N., & Umekar, M. (2025). Artificial intelligence in pharmaceutical sci-ences: Transforming drug discovery, development, and healthcare. International Journal of Pharmaceutical Sciences, 3(7), 811–819.
    34. Terry, D., Phan, H., Peck, B., Hills, D., Kirschbaum, M., Bishop, J., Obamiro, K., Hoang, H., Nguyen, H., Baker, E., & Schmitz, D. (2021). Factors contributing to the recruitment and retention of rural pharmacist workforce: A systematic review. BMC Health Services Research, 21(1), 394. https://doi.org/10.1186/s12913-021-07072-1.
    35. Thomas, J., & Harden, A. (2008). Methods for the thematic synthesis of qualitative research in systematic reviews. BMC Medical Research Method-ology, 8, 45. https://doi.org/10.1186/1471-2288-8-45.
    36. Tumpa, K. F., Arafin, M., & Zohora, F. T. (2024). The impact of knowledge management on employee innovation capabilities: An empirical study of the pharmaceutical industry in Bangladesh. Asian Journal of Economics, Business and Innovation, 3(3), 45–56. https://doi.org/10.54536/ajebi.v3i3.3544.
    37. Wash, G. (2023). Improving employee performance through corporate education. SSRN Electronic Journal. https://doi.org/10.2139/ssrn.4341798.
    38. Wu, X.-Y. (2023). Exploring the effects of digital technology on deep learning: A meta-analysis. Education and Information Technologies, 29(1), 425–448. https://doi.org/10.1007/s10639-023-12307-1.

  • Downloads

  • How to Cite

    U, M. U. S., & Sirisetti, D. S. . (2025). Learning and Development for Innovation and Resilience in The ‎Pharmaceutical Industry. International Journal of Accounting and Economics Studies, 12(8), 183-192. https://doi.org/10.14419/bjsjp624